上海博研生物工程研究ZX为您现货提供*的产品与服务,本ZX产品齐全,保证实验的有效性,提供,是您科研实验产品的一站式平台,咨询。!
产品名称:人纤维蛋白原抗体,Anti-human Fibrinogen优质服务
中文名称:人纤维蛋白原抗体
英文名称:Anti-human Fibrinogen
产品编号:BYK-1240R
产品别名: FGA; FGA protein; FGB; FGG; Fib2; Fibrin alpha chain ;Fibrinogen A alpha polypeptide; Fibrinogen A alpha polypeptide chain; Fibrinogen alpha chain; Fibrinogen B alpha polypeptide; Fibrinogen beta chain; Fibrinogen G alpha polypeptide; Fibrinogen gamma chain; MGC104327; MGC119422; MGC119423; MGC119425; MGC120405; FIBA_HUMAN.
本公司另供应“人纤维蛋白原抗体”的标记有:Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
产品规格:100ug/200ug
产品浓度: 1mg/1ml
抗体来源:兔源、鼠源、山羊
克 隆:单克隆抗体、多克隆抗体
抗体类型:一抗
性 状: 冻干粉或液体
保存条件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
人纤维蛋白原抗体,Anti-human Fibrinogen优质服务技术说明,产品推荐,由于篇幅原因,更多信息请:
Anti-EAAT1/Glast(Excitatory amino acid transporters 1) 胶质细胞谷氨酸运载蛋白1 抗体
Anti-EAAT2 (Excitatory amino acid transporters 2) 抗胶质细胞谷氨酸运载蛋白2抗体
Anti-EAAT3(Excitatory amino acid transporters 3) 抗胶质细胞谷氨酸运载蛋白3抗体
Anti-EBNA-3A (Epstein Barr nuclear antigens 3) EB病毒核抗原-3A抗体
Anti-ECE1(Endothelin Converting Enzyme 1) 内皮素转化酶1抗体
Anti-ECE2(Endothelin Converting Enzyme 2) 抗内皮素转化酶2抗体
Anti-ECG2 (Esophagus cancer-related gene-2) 食道癌相关基因抗体
Anti-ECM1 (extracellular matrix protein 1) 细胞外基质蛋白1抗体
Anti-ECP(eosinophil cationic protein) 抗嗜酸性粒细胞阳离子蛋白抗体
Anti-ED-1 (Ectodermal Dysplasia 1) 外胚层发育不良抗体
Anti-EDNR-A(Endothelin receptor type A) 抗内皮素受体A抗体
Anti-EGFR (Epidemal growth factor receptor) 表皮生长因子受体抗体
Anti-EGF(Epidermal growth factor)to human 表皮生长因子抗体(人)
Anti-Socs 1/FITC 荧光素标记细胞因子信号传导YZ蛋白1抗体IgG
Anti-Socs 2/FITC 荧光素标记细胞因子信号传导YZ蛋白2抗体IgG
Anti-Socs 3/FITC 荧光素标记细胞因子信号传导YZ蛋白3抗体IgG
Anti-SOD1/FITC 荧光素标记超氧化物歧化酶1抗体IgG
产品介绍:
Fibrinogen is the main protein of blood coagulation system. It is a large protein and it consists of two identical subunits that contain three polypeptide chains: alpha, beta and gamma. All chains are connected with each other by a number of disulfide bonds. Fibrinopeptides A (1 to 16 amino acids) and B (1 to 17 amino acids) are released by thrombin from the N terminal parts of alpha and beta chains, respectively. In this way fibrinogen is converted into fibrin, which by means of polymerization forms a fibrin clot. Fibrinogen clotting underlies pathogenesis of MI, thromboembolism and thromboses of arteries and veins, since fibrin is the main substrate for thrombus formation. Fibrinogen activation is also involved in pathogenesis of inflammation, tumor growth and many other diseases. The normal fibrinogen concentration in plasma is about 3 mg/ml. The elevated level of fibrinogen in patient's blood is regarded as an independent risk factor for cardiovascular diseases. An increase in blood fibrinogen concentration was shown to be a strong predictor of coronary heart disease (Sonel A. et al, and Rapold H.J. et al). All these facts make fibrinogen an important parameter in the diagnosis of cardiovascular diseases.